Similar Items: Assessment of point-of-care testing for prediction of aromatase inhibitor-associated side effects in obese postmenopausal breast cancer patients screened for cardiovascular risk factors
- Bone health in post-menopausal patients with breast cancer treated with aromatase inhibitors: factors predicting the risk for osteoporosis.
- Investigating the effects of progestins used in contraception and menopausal hormone therapy on aromatase expression and activity
- CARDIOVASCULAR RISK FACTORS IN PREMENOPAUSAL WOMEN WITH BREAST CANCER AFTER OOPHORECTOMY
- An investigation into the effects of Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants on sperm parameters - an in vitro study
- Epacs exchange protein directly activated by cAMP role in obesity-induced cardiovascular diseases
- Sex hormones and their relationship with leptin and cardiovascular risk factors in pre and post-menopausal Nigerian women with metabolic syndrome
Author: Akudugu, John M.
- Assessment of point-of-care testing for prediction of aromatase inhibitor-associated side effects in obese postmenopausal breast cancer patients screened for cardiovascular risk factors
- Evaluation of BCL-2 and PARP-1 as potential therapeutic targets to radiosensitise lung cancer
- Radiosensitisation of low HER-2 expressing human breast cancer cell lines
- Evaluation of small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 for their radiomodulatory effects in human breast cancer cell lines
- Evaluation of the BCL-2, PI3K, PARP-1, and HSP90 pathways in breast, lung and glial cell lines for identification of candidate genes as therapeutic targets for overcoming radioresistance.
- Evaluation of the effect of low and intermediate frequency electromagnetic waves on radiosensitivity